As previous studies revealed that intact BAX/BAK machinery is required for the anti-tumor effects of BH3-mimetics [65, 66], we confirmed the expression of BAX and BAK in all tested osteosarcoma cell lines. This evidence concerns the gene BAK1 and neoplasm.